Research Article
A Higher Frequency of CD4+CXCR5+ T Follicular Helper Cells in Adult Patients with Minimal Change Disease
Table 2
The effect of treatment on the values of clinical measures in the follow-up MCD patients.
| | | Pretreatment | Posttreatment |
| | Age, years | 46 (21–61) | 46 (21–61) | | Female/male | 1/6 | 1/6 | | Urinary protein, g/24 h | 8.96 (6–19.22) | 3.22 (0.97–5.27)* | | Serum uric acid, mol/L | 357 (198–411) | 343 (227–421) | | Triglycerides, mmol/L | 1.81 (1.55–6.53) | 1.58 (0.57–2.98) | | Cholesterol, mmol/L | 9.85 (6.2–11.57) | 9.09 (5.67–10.45) | | eGFR, mL/min/1.73 m2 | 85.24 (35.31–114.2) | 83.27 (57.46–121.27) | | Serum albumin, g/L | 15.3 (11–33.2) | 17.5 (14.3–39.2) | | Microscopic hematuria, rbc/hpf | 3.6 (1.1–16.2) | 2.8 (0.9–14.6) | | WBC 109/L | 8.1 (4.02–15.08) | 6.03 (4.98–9.23) | | Lymphocytes 109/L | 2.01 (0.83–4.13) | 2.07 (0.53–3.95) |
|
|
Data are present as median (range). versus the values before treatment.
|
